UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III CheckMate 066 study

Annals of oncology, 2016-10, Vol.27 (10), p.1940-1946

2016

Volltextzugriff (PDF)

Survival and Tumor Response Outcomes in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN): A Systematic Literature Review

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (4), p.968-969

2016

Volltextzugriff (PDF)

Long-term survivorship for patients with non-small cell lung cancer (NSCLC) treated with nivolumab (nivo): a response-based modeling approach

European journal of cancer (1990), 2017-02, Vol.72, p.S135-S136

2017

Volltextzugriff (PDF)

3011 Evaluation of overall health status in patients with advanced squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 017

European journal of cancer (1990), 2015-09, Vol.51, p.S599-S600

2015

Volltextzugriff (PDF)

A new data analysis technique to examine crack tip opening angle values tested in API X65 pipe steel

Fatigue & fracture of engineering materials & structures, 2013-07, Vol.36 (7), p.614-622

2013

Volltextzugriff (PDF)

Economic impact of switching from valsartan to other angiotensin receptor blockers in patients with hypertension

Current medical research and opinion, 2010-04, Vol.26 (4), p.849-860

2010

Volltextzugriff (PDF)

PND61 Impact of Patient Cost-Sharing Arrangements for Disease Modifying Therapies on Treatment Compliance among Patients with Multiple Sclerosis in the United States

Value in health, 2011-11, Vol.14 (7), p.A328-A329

2011

Volltextzugriff (PDF)

P02.02 Treatment and Outcomes in Glioblastoma Multiforme: A multi-country chart review study

Neuro-oncology (Charlottesville, Va.), 2017-05, Vol.19 (suppl_3), p.iii32-iii32

2017

Volltextzugriff (PDF)

P02.03 Real-world treatment patterns in glioblastoma multiforme (GBM)

Neuro-oncology (Charlottesville, Va.), 2017-05, Vol.19 (suppl_3), p.iii32-iii32

2017

Volltextzugriff (PDF)

P18.10 Impact of glioblastoma multiforme (GBM) on patients’ quality of life (QoL)

Neuro-oncology (Charlottesville, Va.), 2017-05, Vol.19 (suppl_3), p.iii123-iii123

2017

Volltextzugriff (PDF)

442O Overall health status (HS) in patients (pts) with advanced (adv) non-squamous (NSQ) NSCLC treated with nivolumab (nivo) or docetaxel (doc) in CheckMate 057

Annals of oncology, 2016-12, Vol.27, p.ix141-ix142

2016

Volltextzugriff (PDF)

442O Overall health status (HS) in patients (pts) with advanced (adv) non-squamous (NSQ) NSCLC treated with nivolumab (nivo) or docetaxel (doc) in CheckMate 057

Annals of oncology, 2016-12, Vol.27 (suppl_9)

2016

Volltextzugriff (PDF)

1329 - Long-term survivorship for patients with non-small cell lung cancer (NSCLC) treated with nivolumab (nivo): a response-based modeling approach

European journal of cancer (1990), 2017-02, Vol.72, p.S135-S136

2017

Volltextzugriff (PDF)

460P Evaluation of overall health status in patients with advanced squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 017

Annals of oncology, 2015-12, Vol.26, p.ix125-ix125

2015

Volltextzugriff (PDF)

A REAL-WORLD CLAIMS ANALYSIS OF GLIOBLASTOMA COST OF CARE IN THE UNITED STATES

Value in health, 2017-05, Vol.20 (5), p.A360

2017

Volltextzugriff (PDF)

Overall health status (HS) in patients (pts) with advanced (adv) non-squamous (NSQ) NSCLC treated with nivolumab (nivo) or docetaxel (doc) in CheckMate 057

Annals of oncology, 2016-10, Vol.27, p.vi421-vi421

2016

Volltextzugriff (PDF)

PCN187 - Overall Survival, Health-Related Quality of Life, and Healthcare Resource Use: Independent Analyses from Checkmate 025, A Phase Iii Study of Nivolumab Versus Everolimus in Patients with Advanced or Metastatic Clear-Cell Renal Cell Carcinoma

Value in health, 2016-05, Vol.19 (3), p.A167-A167

2016

Volltextzugriff (PDF)

Overall Survival, Health-Related Quality of Life, and Healthcare Resource Use: Independent Analyses from Checkmate 025, A Phase Iii Study of Nivolumab Versus Everolimus in Patients with Advanced or Metastatic Clear-Cell Renal Cell Carcinoma

Value in health, 2016-05, Vol.19 (3), p.A167-A167

2016

Volltextzugriff (PDF)

PCN21 - Overall Survival (Os), Quality Of Life (Qol), And Neurocognitive Function (Nf) In Recurrent Glioblastoma Multiforme (Gbm): A Systematic Literature Review

Value in health, 2015-11, Vol.18 (7), p.A433-A433

2015

Volltextzugriff (PDF)

Overall Survival (Os), Quality Of Life (Qol), And Neurocognitive Function (Nf) In Recurrent Glioblastoma Multiforme (Gbm): A Systematic Literature Review

Value in health, 2015-11, Vol.18 (7), p.A433-A433

2015

Volltextzugriff (PDF)

Overall Survival (Os) And Quality-Of-Life (Qol) Outcomes In Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck (Scchn): A Systematic Literature Review

Value in health, 2015-11, Vol.18 (7), p.A433-A434

2015

Volltextzugriff (PDF)

PCN25 - Overall Survival (Os) And Quality-Of-Life (Qol) Outcomes In Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck (Scchn): A Systematic Literature Review

Value in health, 2015-11, Vol.18 (7), p.A433-A434

2015

Volltextzugriff (PDF)

Relating Relapse and T2 Lesion Changes to Disability Progression in MS: A Systematic Literature Review and Regression Analysis (P05.090)

Neurology, 2012-04, Vol.78 (Meeting Abstracts 1), p.P05-P05.090

2012

Volltextzugriff (PDF)

PCV33 MONITORING OF LIPID LEVELS AND ADVERSE EVENTS AMONG TEXAS MEDICAID PATIENTS ON STATIN THERAPY

Value in health, 2005-05, Vol.8 (3), p.270-271

2005

Volltextzugriff (PDF)

PCV29 PREDICTORS OF COMPLIANCE AND PERSISTENCE TO STATIN THERAPY AMONG TEXAS MEDICAID PATIENTS

Value in health, 2005-05, Vol.8 (3), p.269-269

2005

Volltextzugriff (PDF)

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(157)

Publikationsform

Sprache

Englisch
(163)
Deutsch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III CheckMate 066 study

Survival and Tumor Response Outcomes in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN): A Systematic Literature Review

Long-term survivorship for patients with non-small cell lung cancer (NSCLC) treated with nivolumab (nivo): a response-based modeling approach

3011 Evaluation of overall health status in patients with advanced squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 017

A new data analysis technique to examine crack tip opening angle values tested in API X65 pipe steel

Economic impact of switching from valsartan to other angiotensin receptor blockers in patients with hypertension

PND61 Impact of Patient Cost-Sharing Arrangements for Disease Modifying Therapies on Treatment Compliance among Patients with Multiple Sclerosis in the United States

P02.02 Treatment and Outcomes in Glioblastoma Multiforme: A multi-country chart review study

P02.03 Real-world treatment patterns in glioblastoma multiforme (GBM)

P18.10 Impact of glioblastoma multiforme (GBM) on patients’ quality of life (QoL)

442O Overall health status (HS) in patients (pts) with advanced (adv) non-squamous (NSQ) NSCLC treated with nivolumab (nivo) or docetaxel (doc) in CheckMate 057

442O Overall health status (HS) in patients (pts) with advanced (adv) non-squamous (NSQ) NSCLC treated with nivolumab (nivo) or docetaxel (doc) in CheckMate 057

1329 - Long-term survivorship for patients with non-small cell lung cancer (NSCLC) treated with nivolumab (nivo): a response-based modeling approach

460P Evaluation of overall health status in patients with advanced squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 017

A REAL-WORLD CLAIMS ANALYSIS OF GLIOBLASTOMA COST OF CARE IN THE UNITED STATES

Overall health status (HS) in patients (pts) with advanced (adv) non-squamous (NSQ) NSCLC treated with nivolumab (nivo) or docetaxel (doc) in CheckMate 057

PCN187 - Overall Survival, Health-Related Quality of Life, and Healthcare Resource Use: Independent Analyses from Checkmate 025, A Phase Iii Study of Nivolumab Versus Everolimus in Patients with Advanced or Metastatic Clear-Cell Renal Cell Carcinoma

Overall Survival, Health-Related Quality of Life, and Healthcare Resource Use: Independent Analyses from Checkmate 025, A Phase Iii Study of Nivolumab Versus Everolimus in Patients with Advanced or Metastatic Clear-Cell Renal Cell Carcinoma

PCN21 - Overall Survival (Os), Quality Of Life (Qol), And Neurocognitive Function (Nf) In Recurrent Glioblastoma Multiforme (Gbm): A Systematic Literature Review

Overall Survival (Os), Quality Of Life (Qol), And Neurocognitive Function (Nf) In Recurrent Glioblastoma Multiforme (Gbm): A Systematic Literature Review

Overall Survival (Os) And Quality-Of-Life (Qol) Outcomes In Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck (Scchn): A Systematic Literature Review

PCN25 - Overall Survival (Os) And Quality-Of-Life (Qol) Outcomes In Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck (Scchn): A Systematic Literature Review

Relating Relapse and T2 Lesion Changes to Disability Progression in MS: A Systematic Literature Review and Regression Analysis (P05.090)

PCV33 MONITORING OF LIPID LEVELS AND ADVERSE EVENTS AMONG TEXAS MEDICAID PATIENTS ON STATIN THERAPY

PCV29 PREDICTORS OF COMPLIANCE AND PERSISTENCE TO STATIN THERAPY AMONG TEXAS MEDICAID PATIENTS

Suchergebnisse filtern